334 related articles for article (PubMed ID: 23144892)
1. MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response.
Testa JS; Shetty V; Hafner J; Nickens Z; Kamal S; Sinnathamby G; Philip R
PLoS One; 2012; 7(11):e48484. PubMed ID: 23144892
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the affinity of influenza A virus protein epitopes for swine MHC I by a modified in vitro refolding method indicated cross-reactivity between swine and human MHC I specificities.
Fan S; Wang Y; Wang X; Huang L; Zhang Y; Liu X; Zhu W
Immunogenetics; 2018 Nov; 70(10):671-680. PubMed ID: 29992375
[TBL] [Abstract][Full Text] [Related]
3. Broadly Reactive Influenza Antibodies Are Not Limited by Germinal Center Competition with High-Affinity Antibodies.
Keating R; Johnson JL; Brice DC; Labombarde JG; Dent AL; McGargill MA
mBio; 2020 Nov; 11(6):. PubMed ID: 33144374
[TBL] [Abstract][Full Text] [Related]
4. A Role of Influenza Virus Exposure History in Determining Pandemic Susceptibility and CD8+ T Cell Responses.
Quiñones-Parra SM; Clemens EB; Wang Z; Croom HA; Kedzierski L; McVernon J; Vijaykrishna D; Kedzierska K
J Virol; 2016 Aug; 90(15):6936-6947. PubMed ID: 27226365
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation threshold.
Valkenburg SA; Gras S; Guillonneau C; La Gruta NL; Thomas PG; Purcell AW; Rossjohn J; Doherty PC; Turner SJ; Kedzierska K
PLoS Pathog; 2010 Aug; 6(8):e1001039. PubMed ID: 20711359
[TBL] [Abstract][Full Text] [Related]
6. Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia.
Price GE; Ou R; Jiang H; Huang L; Moskophidis D
J Exp Med; 2000 Jun; 191(11):1853-67. PubMed ID: 10839802
[TBL] [Abstract][Full Text] [Related]
7. Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.
Moise L; Terry F; Ardito M; Tassone R; Latimer H; Boyle C; Martin WD; De Groot AS
Hum Vaccin Immunother; 2013 Jul; 9(7):1598-607. PubMed ID: 23846304
[TBL] [Abstract][Full Text] [Related]
8. Conserved MHC class I-presented dengue virus epitopes identified by immunoproteomics analysis are targets for cross-serotype reactive T-cell response.
Testa JS; Shetty V; Sinnathamby G; Nickens Z; Hafner J; Kamal S; Zhang X; Jett M; Philip R
J Infect Dis; 2012 Feb; 205(4):647-55. PubMed ID: 22246683
[TBL] [Abstract][Full Text] [Related]
9. A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.
Babon JA; Cruz J; Ennis FA; Yin L; Terajima M
J Virol; 2012 Sep; 86(17):9233-43. PubMed ID: 22718815
[TBL] [Abstract][Full Text] [Related]
10. Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections.
Zhong W; Liu F; Dong L; Lu X; Hancock K; Reinherz EL; Katz JM; Sambhara S
PLoS One; 2010 May; 5(5):e10583. PubMed ID: 20485501
[TBL] [Abstract][Full Text] [Related]
11. Structural and Biochemical Analyses of Swine Major Histocompatibility Complex Class I Complexes and Prediction of the Epitope Map of Important Influenza A Virus Strains.
Fan S; Wu Y; Wang S; Wang Z; Jiang B; Liu Y; Liang R; Zhou W; Zhang N; Xia C
J Virol; 2016 Aug; 90(15):6625-6641. PubMed ID: 27170754
[TBL] [Abstract][Full Text] [Related]
12. The immunodominant influenza A virus M158-66 cytotoxic T lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans.
Choo JA; Liu J; Toh X; Grotenbreg GM; Ren EC
J Virol; 2014 Sep; 88(18):10613-23. PubMed ID: 24990997
[TBL] [Abstract][Full Text] [Related]
13. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
14. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
[TBL] [Abstract][Full Text] [Related]
15. Highly conserved influenza T cell epitopes induce broadly protective immunity.
Eickhoff CS; Terry FE; Peng L; Meza KA; Sakala IG; Van Aartsen D; Moise L; Martin WD; Schriewer J; Buller RM; De Groot AS; Hoft DF
Vaccine; 2019 Aug; 37(36):5371-5381. PubMed ID: 31331771
[TBL] [Abstract][Full Text] [Related]
16. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.
Budimir N; Huckriede A; Meijerhof T; Boon L; Gostick E; Price DA; Wilschut J; de Haan A
PLoS One; 2012; 7(1):e30898. PubMed ID: 22303469
[TBL] [Abstract][Full Text] [Related]
17. Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.
Alam S; Sant AJ
J Virol; 2011 Dec; 85(24):13310-21. PubMed ID: 21976658
[TBL] [Abstract][Full Text] [Related]
18. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
[TBL] [Abstract][Full Text] [Related]
19. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.
Cheuk E; D'Souza C; Hu N; Liu Y; Lang H; Chamberlain JW
J Immunol; 2002 Nov; 169(10):5571-80. PubMed ID: 12421934
[TBL] [Abstract][Full Text] [Related]
20. Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.
Potter P; Tourdot S; Blanchard T; Smith GL; Gould KG
J Gen Virol; 2001 May; 82(Pt 5):1069-1074. PubMed ID: 11297681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
